# A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

> **NCT06783621** · PHASE4 · COMPLETED · sponsor: **AbbVie** · enrollment: 130 (actual)

## Conditions studied

- Facial Contouring

## Interventions

- **DRUG:** OnabotulinumtoxinA
- **DEVICE:** JUVÉDERM
- **DEVICE:** CoolSculpting Elite System
- **OTHER:** SkinMedica Products
- **DRUG:** KYBELLA

## Key facts

- **NCT ID:** NCT06783621
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-16
- **Primary completion:** 2026-02-26
- **Final completion:** 2026-02-26
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06783621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06783621, "A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06783621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*